Skip to main content
Lippincott Open Access logoLink to Lippincott Open Access
. 2026 Jun 17;34(4):e471. doi: 10.1097/jnr.0000000000000752

Relationships Among Type D Personality, Symptoms, Depression and Anxiety, and Quality of Life in Patients With Gastroesophageal Reflux Disease

Yusun PARK 1, Boram CHA 2, Hye Young KIM 3, Sung Reul KIM 4,*
PMCID: PMC13465697  PMID: 42306843

Abstract

Background:

Patients with gastroesophageal reflux disease (GERD) often experience typical or atypical symptoms accompanied by depression, anxiety, and low quality of life (QoL). In patients with various diseases, having a Type D personality has been linked to an elevated risk of developing symptoms such as depression and anxiety, as well as reduced QoL.

Purpose:

The objectives of this study were to examine the influence of Type D personality on GERD symptoms, depression and anxiety, and QoL and to identify the causal relationships among the variables influencing QoL in patients with GERD.

Methods:

A cross-sectional correlational design and convenience sampling were used, and 149 patients with GERD were enrolled as study participants from the gastroenterology outpatient clinic of a university hospital in the Republic of Korea. Data were collected using structured questionnaires and tested using SPSS 28.0 and Amos 23.0.

Results:

Approximately 46% of the participants met the criteria for inclusion in the Type D personality group. This group exhibited higher levels of depression and anxiety and diminished QoL than the non–Type D personality group. In the multiple regression model, GERD symptoms, depression and Type D personality were found to have a significant influence on QoL. In the structural equation model, GERD symptoms, depression, and Type D personality were shown to affect QoL, explaining 51.7% of the total variance in QoL. Two factors, namely depression and GERD symptoms, were identified as mediators of the association between Type D personality and QoL.

Conclusions:

The results of this study indicate a relatively high frequency of Type D personality among patients with GERD. When assessing QoL in patients with GERD, it is essential to consider the influence of Type D personality in conjunction with symptom experience and the presence of depression and anxiety. In particular, managing depression and symptoms in patients with GERD and a Type D personality may offer an effective approach to improving QoL in this patient group.

Key Words: depression, gastroesophageal reflux, quality of life, symptom, Type D personality

Introduction

The global prevalence of gastroesophageal reflux disease (GERD) is 13.98%, with an estimated 1.03 billion sufferers worldwide (Nirwan et al., 2020). A large community-based survey of 71,000 individuals in the United States revealed 44.1% exhibited symptoms of GERD and that 35.1% had received related treatments (Delshad et al., 2020). GERD is characterized by the reflux of stomach contents into the esophagus or beyond, reaching the oral cavity, larynx, or lungs, and leading to symptoms or complications (Radovanovic et al., 2021). If left untreated, GERD can cause serious complications, including esophageal strictures, esophagitis, Barrett’s esophagus, and esophageal adenocarcinoma (Maret-Ouda et al., 2020). GERD has also been linked to chronic respiratory diseases such as aspiration bronchitis and chronic obstructive pulmonary disease (Lee et al., 2020).

Patients with GERD typically experience symptoms such as heartburn, retrosternal pain, and regurgitation, along with atypical symptoms such as a sensation of having a lump in the throat (globus), sore throat, hoarseness, or chronic cough (Jung et al., 2018). These symptoms have been shown to negatively affect quality of life (QoL) in these patients (Alzahrani et al., 2023; Fuchs et al., 2022), with approximately 83.3% of patients with GERD reporting a poor QoL (Alzahrani et al., 2023). Therefore, GERD-related symptoms and QoL are pivotal factors in the treatment and management of patients with GERD (Chen & Brady, 2019).

Psychological factors, including depression, anxiety, and stress, are widely acknowledged as significant risk factors for symptoms and QoL in GERD patients (Wickramasinghe et al., 2023; Zamani et al., 2023). Stress can precede conditions such as functional dyspepsia and heartburn and can aggravate GERD symptoms by amplifying perceptual responses to intraesophageal acid stimuli via central mechanisms without increasing the volume of acid reflux (Sandhu & Fass, 2018). Stress can increase the perception of intraesophageal acid exposure and impact health behaviors such as alcohol consumption, diet, physical activity, and smoking, all of which affect the risk of reflux (Boulton & Dettmar, 2022). Moreover, stress may diminish the effectiveness of treatment in GERD patients (Sandhu & Fass, 2018). Stress-relieving interventions have previously been shown to enhance the QoL and symptom experience of patients with GERD (Chandran et al., 2023).

Type D personality, associated with tendencies toward negative affectivity and social inhibition, has been strongly associated with stress (Denollet, 2005). Patients with chronic diseases frequently experience depression and anxiety (Fattouh et al., 2019), and social isolation or withdrawal is closely related to their physical and psychosocial symptoms experience (Iovino et al., 2023; Ahn et al., 2022). The findings of prior research show people with Type D personality to be more prone to chronic stress (Gębska et al., 2022) and tend to have worse disease outcomes (Raykh et al., 2022). Patients with a Type D personality and a chronic illness, such as psoriasis, stroke, diabetes, or brain tumor, have been shown to experience higher depression and anxiety, more severe symptoms, reduced self-management, and lower QoL than their non–Type D personality peers with these illnesses (Aguayo Carreras et al., 2020; Akbari et al., 2020; Kim, Kim, et al., 2021; Kim, Nho, et al., 2021).

Patients with GERD frequently experience depression and anxiety, and GERD symptoms that affect their social functioning (Mohammad et al., 2019). Moreover, having a Type D personality has been related to unhealthy behaviors (Buczkowska et al., 2022), which are significant contributors to the onset and progression of symptoms in patients with GERD (Wang et al., 2021). Specifically, patients with functional gastrointestinal disorders report impaired health-related QoL and severe gastrointestinal symptoms (Hansel et al., 2010). Given the relationship between Type D personality and higher depression, anxiety, and stress sensitivity, this personality type may be significantly related to depression and anxiety, GERD symptoms, and QoL in patients diagnosed with GERD. The focus of most previous related studies has been on investigating the associations between Type D personality, symptoms, and QoL in patients with chronic diseases, with few studies reporting a causal relationship between the direct and indirect effects of Type D personality on symptoms and QoL. Moreover, few studies have been published on the influence of Type D personality on symptoms, depression, anxiety, or QoL in patients with GERD. Therefore, this study was designed to examine the influence of Type D personality on GERD symptoms, depression, anxiety, and QoL and to identify the causal relationships among the variables influencing QoL in patients with GERD.

Methods

Sample

In this descriptive, cross-sectional study, patients were recruited using convenience sampling from the gastroenterology outpatient clinic of a university hospital in the Republic of Korea. The inclusion criteria were the following: (a) diagnosis of GERD by a gastroenterologist, (b) aged 20 years or older, and (c) able to communicate in Korean. The exclusion criteria were having a chronic medical condition such as chronic renal failure, heart failure, or active cancer that may affect symptoms, health behaviors, and QoL.

Multiple linear regression was performed to determine the appropriate sample size using G*Power 3.1.9.7. The sample size estimation was based on a significance level of .05, power of 0.80, median effect size of 0.15, regression analysis (Faul et al., 2009), and 17 predictors. Based on these criteria, a minimum sample size of 146 was required. In addition, the suggestion of Kline (2023) that a sample size within the range of 100–200 is generally needed for structural equation modeling (SEM) to ensure sufficient statistical power and robustness was followed.

Data Collection

Data were collected between July 2022 and March 2023 using a structured questionnaire.

Type D Personality

Type D personality was assessed using the Korean version of the Type D Personality Scale-14 (Denollet, 2005; Lim et al., 2011). This scale consists of 14 items distributed across two domains: negative affectivity and social inhibition. Each item is evaluated using a 5-point Likert scale ranging from 0 to 4, with respondents earning subtotal scores of 10 or above in both domains classified as having a Type D personality. In this study, the Cronbach’s alpha was .86 for negative affectivity and .84 for social inhibition.

GERD Symptoms

The GERD symptoms experience of participants was evaluated using the Korean version of the Self-Evaluation Questionnaire for Gastroesophageal Reflux Disease (SEQ-GERD; Jung et al., 2018). This scale has been validated for reliability, including internal consistency (Cronbach’s alpha=.60–.94), test–retest reliability (intraclass correlation coefficient=.67–.95), and validity through its relationship to QoL (r=−.54) in the Korean context (Jung et al., 2018). The scale comprises six items distributed across two dimensions, namely the domains of GERD and upper GI symptoms. Each item is designed to evaluate symptom severity and frequency using a 5-point Likert scale, with scores ranging from 1 to 5. The scores are aggregated to create a sum score for the frequency and severity of each symptom, with a total score ranging from 12 to 60, and higher scores indicating a stronger symptom experience. The Cronbach’s alpha for this study was .79.

Depression

The Korean version of the Patient Health Questionnaire-9 was used to assess depression in this study (Han et al., 2008; Kroenke et al., 2001). The scale comprises nine items, each of which reflects a single criterion for major depressive disorder. Each item is rated on a 4-point Likert scale, with scores ranging from 0 to 3. Total scores range from 0 to 27, with higher scores indicating more severe depressive symptoms. The Cronbach’s alpha for this study was .88.

Anxiety

The Korean version of the Generalized Anxiety Disorder-7 was used to assess anxiety in this study (Seo & Park, 2015; Spitzer et al., 2006). The Generalized Anxiety Disorder-7 consists of seven items, each addressing a core symptom of generalized anxiety disorder. Each item is rated on a 4-point Likert scale, with scores ranging from 0 to 3. Total scale scores range from 0 to 21, with higher scores indicating more severe anxiety symptoms. The Cronbach’s alpha for this study was .90.

Quality of Life

QoL was evaluated using the Korean version of the Quality of Life Questionnaire for Gastroesophageal Reflux Disease (Chan et al., 2010; Jung et al., 2018), which comprises 17 items distributed across four dimensions: daily activity (DA), treatment effect (TE), diet (DI), and psychological well-being (PW). Each item is rated on a 5-point Likert scale, with scores ranging from 0 to 4. Total scale scores range from 0 to 100, with higher scores indicating higher (better) QoL. Confirmatory factor analysis (CFA) was conducted to test the construct validity of this scale, with factor loadings from .674 to .900 and critical ratios (CR) ranging from 9.117 to 12.798 (p<.001). The model was shown to be suitable, with normed χ²=2.313 (p=.128), goodness of fit index (GFI)=.992, comparative fit index (CFI)=.996, normed fit index (NFI)=.993, Tucker-Lewis index (TLI)=.977, and standardized root mean residual (SRMR)=.010. The Cronbach’s alpha for this scale in this study was .86 for DA, .84 for TE, .86 for DI, and .90 for PW.

General and Clinical Characteristics and Health Behaviors

Participant demographic characteristics, including age, gender, educational level, marital status, family income, and occupation, were collected using a self-report datasheet and evaluated. Clinical characteristics were evaluated using interviews and medical records, and disease duration was also assessed. The health behaviors of the participants were evaluated using the following seven items derived from Zhang et al. (2021): (a) body mass index, (b) alcohol consumption, (c) tea and coffee intake, (d) eating habits (late-night snacking, dinner within 2 hours of going to bed, frequency of breakfast, and quick eating), (e) exercise, (f) insufficient sleep (subjective perception of insufficient sleep), and (g) cigarette use. The researcher measured body mass index, and the remaining items were investigated using a questionnaire.

Data Analysis

Statistical analyses were conducted using IBM SPSS Statistics Version 28.0 (IBM Corp., Armonk, NY, USA) and AMOS 23.0. The demographic and clinical characteristics and study variables were analyzed using descriptive statistics. Type D personality was evaluated in relation to demographic and clinical characteristics; symptoms, depression and anxiety, health behaviors, and QoL were evaluated using the independent t test, χ2 test, Mann–Whitney U test, and Fisher’s exact test; QoL scores were analyzed in relation to demographic and clinical characteristics and health behaviors using one-way analysis of variance, independent t tests, and post hoc Scheffe tests; and Pearson’s correlation coefficients were used to assess the correlations among the study variables. Stepwise multiple regression analysis was conducted to elucidate the factors of influence on QoL.

In addition, an SEM analysis was conducted to test the causal relationship between the variables affecting QoL. The skewness and kurtosis were tested for normality. Tolerance, variance inflation factor (VIF), and Pearson’s correlation coefficient were evaluated for multicollinearity. To test the fit of the data to the hypothetical model, χ² (p), normed χ², the GFI, the CFI, the NFI, incremental fit index (IFI), and standardized root mean residual (SRMR) were performed. The squared multiple correlations (SMC) of the study variables with QoL in the hypothetical model were also evaluated. Bootstrapping was employed to analyze the indirect, direct, and total effects. The indirect effect of each variable on the multimediation model with multiple indirect effects was tested using a phantom variable. Two-tailed p < .05 was considered to indicate statistical significance.

Ethical Considerations

This study was approved by the institutional review board of Inha University Hospital (No. 2021-04-054). All of the participants were informed that they could withdraw from the study at any time, and their informed written consent was obtained.

Results

Participant Demographic and Clinical Characteristics and Health Behaviors

Of the 177 returned questionnaires, 24 were excluded because of incomplete responses or over 50% of items left unanswered. Thus, data from 149 participants were included in the final analysis.

Participant demographic and clinical characteristics and health behavior information are summarized in Table 1. The average age of the participants was 55.75 (SD=13.96) years, 84 (57.1%) were women, 51 (34.2%) had a disease duration of 36 months or more, 48% exercised for more than 30 min per day, and 66.2% reported insufficient sleep.

Table 1.

Between-Group Comparisons of Demographic and Clinical Characteristics, Health Behaviors, GERD Symptoms, Depression and Anxiety, and Quality of Life (N = 149)

Variable n (%)
Total (n=149) Type D Group (n=69) Non–Type D Group (n=80) t or χ2 p
Age (years; M and SD) 55.75±13.96 54.63±13.88 56.71±14.04 −0.90 .370
Gender a 0.51 .507
 Men 63 (42.9) 27 (39.7) 36 (45.6)
 Women 84 (57.1) 41 (60.3) 43 (54.4)
Marital status a 0.71 .480
 Married 94 (65.7) 41 (62.1) 53 (68.8)
 Not married 49 (34.3) 25 (37.9) 24 (31.2)
Educational level a 0.04 .867
 ≤ High school 58 (39.7) 26 (38.8) 32 (40.5)
 ≥ College 88 (60.3) 41 (61.2) 47 (59.5)
Monthly household income (10,000 KRW/month) a 0.45 .501
 < 300 34 (24.3) 17 (27.0) 17 (22.1)
 ≥ 300 106 (75.7) 46 (73.0) 60 (77.9)
Occupation a 0.83 .404
 No 67 (46.5) 28 (42.4) 39 (50.0)
 Yes 77 (53.5) 38 (57.6) 39 (50.0)
Duration of disease (month) 0.23 .632
 < 36 98 (65.8) 44 (63.8) 54 (67.5)
 ≥ 36 51 (34.2) 25 (36.2) 26 (32.5)
Body mass index (kg/m2; M and SD) a 23.01±3.55 22.88±3.68 23.13±3.45 −0.41 .683
Classification of body mass index (kg/m2) a 2.28 .517
 < 18.5 10 (7.1) 6 (9.1) 4 (5.3)
 18.5–22.9 62 (44.3) 31 (47.0) 31 (40.8)
 23.0–24.9 35 (25.0) 13 (19.7) 22 (28.9)
 ≥ 25 35 (25.0) 16 (24.2) 19 (25.0)
Alcohol consumption 2.22 .155
 No 104 (69.8) 44 (63.8) 60 (75.0)
 Yes 45 (30.2) 25 (36.2) 20 (25.0)
Tea and coffee (times) 2.75 .253
 Hardly drinking 58 (38.9) 22 (26.9) 36 (45.0)
 ≤ 6 times/week 38 (25.5) 19 (27.5) 19 (23.8)
 ≥ daily 53 (35.6) 28 (40.6) 25 (31.3)
Eating habits
 Frequency of late-night snacking (times/week) 3.49 .076
   ≥ 3 33 (22.1) 20 (29.0) 13 (16.3)
 <3 116 (77.9) 49 (71.0) 67 (83.7)
 Dinner within 2 hr of going to bed 3.64 .066
   No 90 (60.4) 36 (52.2) 54 (67.5)
   Yes 59 (39.6) 33 (47.8) 26 (32.5)
 Frequency of breakfast (time/week) 2.92 .102
   ≥ 3 76 (51.0) 30 (43.5) 46 (57.5)
   <3 73 (49.0) 39 (56.5) 34 (42.5)
 Quickly eating 0.68 .510
   No 68 (45.6) 29 (42.6) 39 (48.8)
   Yes 81 (54.4) 40 (58.0) 41 (51.2)
Average exercise (min/day) a 2.83 .102
  <30 77 (52.0) 41 (59.4) 36 (45.6)
  ≥ 30 71 (48.0) 28 (40.6) 43 (54.4)
Insufficient sleep a 5.91 .023
  No 50 (33.8) 16 (23.5) 34 (42.5)
  Yes 98 (66.2) 52 (76.5) 46 (57.5)
Cigarette use 0.13 .811
  No 129 (86.6) 59 (85.5) 70 (87.5)
  Yes 20 (13.4) 10 (14.5) 10 (12.5)
M±SD M±SD M±SD t p
GERD symptoms 24.28±8.56 25.62±8.20 23.13±8.74 1.79 .076
Depression 5.61±5.21 7.87±5.78 3.66±3.73 5.20 <.001
Anxiety 4.36±4.39 6.45±4.73 2.56±3.13 5.99 <.001
Quality of life
 Total 52.80±23.86 44.48±19.97 59.98±24.71 −4.23 <.001
 Daily activity 66.56±22.40 59.67±21.28 72.50±21.74 −3.63 <.001
 Treatment effect 55.17±28.41 44.98±24.19 63.96±28.98 −4.36 <.001
 Diet 50.97±29.39 43.03±26.54 57.81±30.16 −3.15 <.001
 Psychological well-being 38.87±30.35 30.25±25.31 46.30±32.45 −3.39 <.001

Note. GERD = gastroesophageal reflux disease; KRW = South Korean Won.

a These data contain missing data.

Between-Group Comparisons of Demographic and Clinical Characteristics, Health Behaviors, GERD symptoms, Depression and Anxiety, and QoL

The results of between-group comparisons of demographic and clinical characteristics, health behaviors, GERD symptoms, depression and anxiety, and QoL are shown in Table 1.

Sixty-nine (46.3%) of the participants were identified as having a Type D personality and assigned to the Type D personality group. Demographic and clinical characteristics did not differ significantly between the two groups. In terms of health behaviors, all variables were statistically similar between the groups with the exception of “frequency of insufficient sleep,” which was higher in the Type D personality group than the non–Type D personality group (χ2=5.91, p=.023).

The depression and anxiety scores of the Type D personality group were significantly higher than those of the personality non–Type D group (t=5.20, p<.001; t=5.99, p<.001, respectively). The GERD symptom score of the Type D personality group was higher than that of the personality non–Type D group; however, this difference was not statistically significant. In addition, the scores for total DA, TE, DI, and PW were significantly lower in the Type D personality group than in the personality non–Type D group (t=−4.23, p<.001; t=−3.63, p<.001; t=−4.36, p<.001; t=−3.15, p<.001; and t=−3.39, p<.001, respectively; Table 1).

Factors Influencing QoL in Patients With GERD

The results for QoL scores categorized by demographic, clinical characteristic, and health behavior factors are summarized in Table 2. The QoL scores of participants with a disease duration of <3 years were higher than those with a disease duration of ≥3 years (t=−2.55, p= .012). Also, the QoL scores of participants with sufficient sleep were higher than those with insufficient sleep (t=2.30, p=.023). In the correlation analysis between QoL and the study variables, total QoL score was shown to correlate significantly with GERD symptoms (r=−.545, p<.001), depression (r=−.525, p <.001), and anxiety (r=−.462, p <.001). To identify the factors influencing QoL, we performed stepwise multiple regression using statistically significant independent variables (Table 2 and Supplementary Table 1, Supplemental Digital Content 1, http://links.lww.com/JNR/A10). The most significant factor influencing QoL was GERD symptoms (adjusted R 2=.292, p < .001), followed by depression (adjusted R 2=.106, p < .001) and Type D personality (adjusted R 2=.014, p < .001; Table 3).

Table 2.

Quality of Life by Demographic, Clinical, and Health Behavior Characteristics (N= 149)

Variable Mean±SD t or F (p)
Gender −1.61 (.110)
 Male 56.18±25.05
 Female 49.87±22.36
Marital status −0.29 (.769)
 Married 52.91±24.42
 Not married 51.69±21.98
Educational level −0.39 (.697)
 ≤ High school 53.73±23.92
 ≥ College 52.17±23.52
Monthly household income (10,000 won/month) 1.00 (.318)
 <300 55.78±24.97
 ≥300 51.09±23.32
Occupation −0.99 (.322)
 No 50.16±21.75
 Yes 54.02±24.52
Duration of disease (month) −2.55 (.012)
 <36 56.33±24.58
 ≥36 46.03±21.01
Body mass index (kg/m2) 4.31 a (.230)
 <18.5 42.55±17.14
 18.5–22.9 51.76±23.61
 23.0–24.9 58.51±24.69
 ≥25 48.44±22.04
Alcohol consumption −1.67 (.098)
 No 50.67±23.44
 Yes 57.72±24.35
Tea and coffee 2.28 (.106)
 Hardly drinking 47.79±21.74
 ≤ 6 times/week 54.45±26.86
 ≥ daily 57.11±23.24
Eating habits
 Frequency of late-night snack (times/week) 0.90 (.370)
  ≥3 49.50±21.49
  <3 53.74±24.44
 Dinner within 2 hr of going to bed 0.47 (.636)
  No 53.56±25.18
  Yes 51.66±21.85
 Frequency of breakfast (times/week) 0.13 (.899)
  <3 52.55±22.81
  ≥3 53.05±24.98
 Quickly eating 0.49 (.628)
  No 53.84±24.11
  Yes 51.93±23.76
Average daily exercise (min) 0.43 (.670)
 <30 52.07±24.56
 ≥30 53.75±23.35
Insufficient sleep 2.30 (.023)
 No 59.14±24.82
 Yes 49.71±22.92
Cigarette use −0.02 b (.984)
 No 53.84±24.11
 Yes 51.93±23.76

a Kruskal–Wallis test. b Mann–Whitney test.

Table 3.

Stepwise Multiple Regression Analysis of Factors Influencing Quality of Life in Patients With GERD

Variable Step 1 Step 2 Step 3
B β t (p) B β t (p) B β t (p)
(Constant) 90.056 17.97 (<.001) 89.136 19.27 (<.001) 91.181 19.51 (<.001)
GERD symptoms −1.538 −.545 −7.86 (<.001) −1.115 −.395 −5.62 (<.001) −1.132 −.401 −5.77 (<.001)
Depression −1.655 −.362 −5.15 (<.001) −1.371 −.300 −3.98 (<.001)
Type D personality −7.028 −.147 −2.12 (.036)
Adjusted R 2 .292 .398 .412
Change in adjusted R 2 .106 .014
F 61.73 49.51 35.30
p <.001 <.001 <.001

Note. GERD = gastroesophageal reflux disease.

GERD Symptoms and Depression as Mediators in the Relationship Between Type D Personality and QoL

An SEM analysis was conducted to confirm the causal relationships among the variables influencing QoL. The range of skewness was 0.150 to 1.449, and the range of kurtosis was −0.766 to 2.480. Thus, the assumption of the normality of the study variables was met for these criteria. The tolerance of the study variables was 0.712–0.836, and the VIF was 1.196–1.404. The correlation coefficients ranged from .408 to .741. These results indicate an acceptable level of multicollinearity between the observed variables. The hypothetical model was suitable; χ²=4.31 (p < .001), normed χ²=0.00, GFI=.922, CFI=.928, NFI=.909, IFI=.929, SRMR=.045. One of the six paths in the final path model was not supported (Type D personality → GERD symptoms).

The standardized estimates of the direct, indirect, and total effects of the exogenous variables on the endogenous variables are presented in Table 4. Type D personality was shown to have significant direct and total effects on depression (β=.404, 95% CI [.273, .509]; β=.404, 95% CI [.273, .509]) and a significant indirect effect on GERD symptoms (β=.169, 95% CI [.093, .266]), while depression was shown to have significant direct and total effects on GERD symptom (β=.417, 95% CI [.257, .578]; β=.417, 95% CI [.257, .578]). Type D personality (β=−.133, 95% CI [−.272, −.003); β=−.201, 95% CI [−.300, −.093]; β=−.334, 95% CI [−.473, −.184]) and depression (β=−.329, 95% CI [−.469, −.162]; β=−.193, 95% CI [−.301, −.118]; β=−.522, 95% CI [−.637, −.385]) were shown to have significant direct, indirect, and total effects on QoL, while GERD symptoms was shown to have significant direct and total effects on QoL (β=−.462, 95% CI [−.576, −.311]; β=−.462, 95% CI [−.576, −.311]). These findings indicate GERD symptoms and depression mediate the relationship between having a Type D personality and QoL.

Table 4.

Standardized Direct, Indirect, and Total Effects of the Structural Equation Model

Endogenous Variable Standardized Direct Effect Standardized Indirect Effect Standardized Total Effect SMC
β (p) 95% CI β (p) 95% CI β (p) 95% CI
Depression .163
 Type D personality .404 (.001) [.273, .509] .404 (.001) [.273, .509]
GERD symptoms .167
 Type D personality −.023 (.774) [−.163, .120] .169 (.001) [.093, .266] .146 (.086) [−.020, .297]
 Depression .417 (.001) [.257, .578] .417 (.001) [.257, .578]
Quality of life .517
 Type D personality −.133 (.047) [−.272, −.003] −.201 (.001) [−.300, −.093] −.334 (.001) [−.473, −.184]
 Depression −.329 (.001) [−.469, −.162] −.193 (.001) [−.301, −.118] −.522 (.001) [−.637, −.385]
 GERD symptom −.462 (.002) [−.576, −.311] −.462 (.002) [−.576, −.311]

Note. CI = confidence intervals; GERD = gastroesophageal reflux disease; SMC = squared multiple correlation.

To test specific indirect effects, phantom variables were employed for multiple indirect effects. The pathway of Type D personality → GERD symptoms → QoL was denoted as the phantom variable “P1” → “P2”; Type D personality → depression → QoL was denoted as “P3” → “P4”; and Type D personality → depression → GERD symptoms → QoL was denoted as “P5” → “P6” → “P7.” Two indirect effects were found to be significant, and one was found not to reach significance. The indirect effect of P2 (path of Type D personality → GERD symptoms → QoL) was B=0.425 (p=.774, 95% CI [−2.281, 3.306]); the indirect effect of P4 (path of Type D personality → depression → QoL) was B=−5.428 (p=.001, 95% CI [−2.571, −9.211]); and the indirect effect of P7 (path of Type D personality → depression → GERD symptoms → QoL) was B=−3.173 (p=.001, 95% CI [−1.633, −5.617]; Figure 1). The SMC values indicate Type D personality, depression, and GERD symptoms collectively explained 51.7% of the variance in QoL (Table 4 and Figure 1).

Figure 1.

Figure 1

Path of the Hypothetical Model Note GERD = gastroesophageal reflux disease; QoL = quality of life. *p < .05.

Discussion

The strengths of this study are that it revealed the influence of Type D personality on depression, anxiety, GERD symptoms, and QoL in patients with GERD and a causal relationship between Type D personality and the variables affecting QoL. Thus, depression and GERD symptoms were shown to be mediators in the relationship between Type D personality and QoL. Although the relationship between Type D personality and QoL in patients with chronic diseases is well-understood, this relationship in patients with GERD has not been explored. To the best of the authors’ knowledge, this is the first study to use SEM to identify the relationships among Type D personality, symptom experience, depression and anxiety, and QoL in patients with GERD. In addition, the mediators identified in this study help elucidate promising avenues to explore in developing related interventions. Therefore, for GERD patients with a Type D personality, improved management of depression and GERD symptoms in these patients may be effective in improving their QoL.

In this study, nearly half (46.3%) of the participants were identified as having a Type D personality. This is higher than the prevalence of this personality type reported among individuals with functional gastrointestinal disorders (37.0%; Hansel et al., 2010), psoriasis (38.4%; Aguayo Carreras et al., 2020), coronary heart disease (26%; Aluja et al., 2019), and healthy individuals (20.2%; Aluja et al., 2019). Similarly, these results are higher than those reported in studies on other chronic illnesses conducted in Korea (18.4%–34.1%; Kim, Kim, et al., 2021; Kim, Nho, et al., 2021; Park et al., 2022). This finding suggests health care professionals should evaluate whether their patients with GERD have a Type D personality.

Anxiety, depression, and QoL scores were shown to be higher in the Type D personality group than in the non–Type D personality group. These results are consistent with previous studies showing Type D personality to be associated with higher anxiety and depression and with lower QoL in patients with chronic diseases (Aguayo Carreras et al, 2020; Can & Tuman, 2020; Hansel et al., 2010; Kim, Kim, et al., 2021; Kim, Nho, et al., 2021). In contrast, the results of this study indicated no significant discrepancy in GERD symptoms between Type D personality and non–Type D personality groups. This may be due to the relatively small sample size used in this study. Nevertheless, despite this lack of a statistically significant between-group difference (p=.076), the GERD score was higher in the Type D personality group. Moreover, having a Type D personality was found in the SEM to indirectly affect the GERD symptom experience. In other words, having a Type D personality exacerbates depression, which negatively affects GERD symptoms. This finding is similar to a previous study in which Type D personality was linked to symptom experiences (Kim et al., 2018). In addition, having a Type D personality was found in the SEM to directly affect depression and QoL. Because Type D personality can directly or indirectly affect symptoms, depression, and QoL in patients with GERD, it is necessary to evaluate and manage depression and GERD symptoms in patients with this personality type to improve their QoL.

In this study, in the SEM, GERD symptoms were found to directly affect QoL and depression was found to have direct and indirect effects on QoL in patients with GERD. These results are consistent with those of previous studies, demonstrating the negative impact of psychological factors and GERD-related symptoms on the QoL of patients with GERD (Alzahrani et al., 2023; Can & Tuman, 2020). Therefore, it is imperative to consider symptoms and depression when assessing the QoL of patients with GERD.

In addition, the multimediation model was analyzed using phantom variables to determine statistically significant paths. As a result, two of the three paths (Type D personality→ depression → QoL and Type D personality→ depression → GERD symptoms → QoL) were found to reach statistical significance, suggesting Type D personality not only directly diminishes QoL but also indirectly influences QoL by exacerbating GERD symptoms and depression. Therefore, it is necessary to consider Type D personality along with depression and GERD symptoms when assessing the QoL of patients with GERD. In particular, depression and symptom management may offer an effective approach to improving QoL in GERD patients with a Type D personality. Moreover, non–Type D individuals may also experience high depression and symptoms and lower QoL. As depression and GERD symptoms are closely related to QoL, QoL may be improved by reducing depression and GERD symptoms. Therefore, even though high depression and symptoms and lower QoL are more common in individuals with Type D personality, strategies for improving QoL may include assessing the level of depression and GERD symptoms in both the Type D personality and other personality-type groups and providing psychological interventions and symptom management to ameliorate these factors.

In this study, seven health behaviors were investigated. The Type D personality group was shown to have a higher frequency of insufficient sleep, which is consistent with findings among patients with psoriasis and myofascial pain syndrome (Aguayo Carreras et al., 2020; Can & Tuman, 2020). Although not statistically significant, a higher frequency of late-night snacking, dinner within 2 hr of going to bed, a lower frequency of breakfast, and fast eating were more frequent in the Type D personality group, potentially exacerbating their GERD symptoms (Zhang et al., 2021). The findings of previous studies indicate that individuals with Type D personality exhibit a significantly lower prevalence than their non–Type D peers of engaging in appropriate health behaviors such as following healthy dietary habits.

In addition, health behaviors such as eating habits, smoking, obesity, and exercise habits have been identified as significant contributors to the onset and progression of symptoms in patients with GERD (Wang et al., 2021; Zhang et al., 2021). Consequently, lifestyle modification, along with proton pump inhibitor medication and surgical procedures such as fundoplication, is a pivotal facet of GERD treatment (Chhabra & Ingole, 2022; Maret-Ouda et al., 2020). In future studies, the relationship between Type D personality and health behaviors, including unhealthy eating habits and insufficient sleep in patients with GERD, should be investigated and clarified.

In this study, patients with GERD with a disease duration of 3 years or less exhibited a higher QoL than their peers with a duration of >3 years. The strong correlation found between GERD duration and symptom duration aligns with the findings of previous studies, suggesting that patients with shorter symptom duration report better QoL than those with prolonged symptom duration (Lail et al., 2019). Therefore, it is imperative to actively implement interventions aimed at preventing chronicity and recurrence of GERD.

This study was affected by several limitations. First, conducting the study at a single institution may limit the generalizability of the results. Second, this study did not investigate all potentially relevant demographic or clinical factors, such as perceived socioeconomic status, treatment modalities (e.g., medication or surgery), comorbidities, and social factors (e.g., social support). Future studies should examine and incorporate these factors to explore their influence on GERD symptoms and QoL. Third, the data collection period was long because it coincided with the coronavirus disease 2019 pandemic and used a face-to-face consent and interview format. Although consistent recruitment methods and inclusion criteria were applied throughout, patients with a high fear of infectious diseases may not have visited the target hospital or may have refused to participate in the face-to-face interview. Finally, the cross-sectional study design precluded the ability to determine whether Type D personality was a cause or consequence of higher depression and anxiety, fewer health behaviors, and lower QoL. Consequently, the causal relationships identified using SEM should be interpreted as indicative rather than definitive due to the inability to establish temporal sequences or confirm true causality using a cross-sectional study design. To address these challenges, future research should implement longitudinal studies to strengthen evidence and clarify the dynamics of these associations. Despite these limitations, significant associations were identified among Type D personality, GERD experience, health behaviors, depression, anxiety, and QoL in patients with GERD. Also, causal relationships among the variables influencing QoL in patients with GERD were confirmed.

The results highlight the necessity for health care professionals to routinely assess depression, anxiety, symptoms, and QoL in patients with GERD and to assess whether patients with high levels of depression, anxiety, and symptoms and low levels of QoL have a Type D personality. In a previous study (Kim et al., 2020), lifestyle interventions based on Type D personality were shown to have positive effects such as reduced obesity, improved health-promoting behaviors, and reduced psychological distress. Another study reported on cognitive therapy in patients with coronary heart disease and Type D personality (Nejati et al., 2022). Therefore, developing cognitive therapy and lifestyle modification interventions tailored to the needs of Type D personality characteristics may prove beneficial in reducing symptoms and improving QoL in GERD patients with this personality type. Future studies are needed to evaluate the effects of interventions tailored to the Type D personality on negative emotions (including anxiety and depression), social inhibition, symptoms, and QoL in patients with GERD.

Conclusions

In patients with GERD, having a Type D personality is significantly related to depression and anxiety severity, health behaviors, and QoL. In patients with GERD, QOL is influenced by GERD symptoms, depression, and personality type. In the SEM, GERD symptoms, depression, and having a Type D personality were all shown to affect QoL, while depression and GERD symptoms were shown to mediate the association between Type D personality and QoL.

Based on the findings, Type D personality should be assessed together with GERD symptoms and depression when assessing QoL in patients with GERD. In particular, managing depression and GERD symptoms may be beneficial strategies for enhancing QoL in GERD patients with Type D personality, and related interventions should be pursued.

Supplementary Material

jnr-34-e471-s001.docx (42.6KB, docx)

Acknowledgment

The authors sincerely thank the patients who participated in this study.

Author Contributions

Study conception and design: All authors

Data collection: BC

Data analysis and interpretation: All authors

Drafting of the article: All authors

Critical revision of the article: YP, SRK

Footnotes

1

Y.P. and B.C. contributed equally.

The authors declare no conflicts of interest.

Cite this article as: Park, Y., Cha, B., Kim, H.Y., & Kim, S.R. (2026). Relationships Among Type-D Personality, Symptoms, Depression and Anxiety, and Quality of Life in Patients With Gastroesophageal Reflux Disease. The Journal of Nursing Research, 00(00), Article e000. https://doi.org/10.1097/jnr.0000000000000752

Supplemental Digital Content is available for this article. Direct URL citations are provided in the HTML and PDF versions of this article on the journal’s website, www.jnr-twna.com.

Contributor Information

Yusun PARK, Email: ysluve@gmail.com.

Boram CHA, Email: chaboram@hanmail.net.

Hye Young KIM, Email: tcellkim@jbnu.ac.kr.

Sung Reul KIM, Email: srkim74@korea.ac.kr.

References

  1. Aguayo Carreras P., Ruiz Carrascosa J. C., Molina Leyva A. 2020. Type D personality is associated with poor quality of life, social performance, and psychological impairment in patients with moderate to severe psoriasis: A cross-sectional study of 130 patients. Indian Journal of Dermatology Venereology and Leprology, 86, 375–381. 10.4103/ijdvl.IJDVL_114_19 [DOI] [PubMed] [Google Scholar]
  2. Ahn S., Springer K., Gibson J. S. 2022. Social withdrawal in Parkinson’s disease: A scoping review. Geriatric Nursing, 48, 258–268. 10.1016/j.gerinurse.2022.10.010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Akbari H., Dehghani F., Salehzadeh M. 2020. The impact of Type D personality on self-care of patients with type 2 diabetes: The mediating role of coping strategies. Journal of Diabetes & Metabolic Disorders, 19, 1191–1198. 10.1007/s40200-020-00624-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Aluja A., Malas O., Lucas I., Worner F., Bascompte R. 2019. Assessment of the Type D personality distress in coronary heart disease patients and healthy subjects in Spain. Personality and Individual Differences, 142, 301–309. 10.1016/j.paid.2018.08.011 [DOI] [Google Scholar]
  5. Alzahrani M. A., Alamri F. S., Alshahrani H. M., Alshahrani A. M., Mohammed A. M., Saif R. A., Alqarni S. A., Godhaif N. A., Al Mudawi A. A. M. 2023. Factors influencing the quality of life of GERD patients in the Aseer Region, Saudi Arabia. Journal of Family Medicine and Primary Care, 12(12), 3217–3221. 10.4103/jfmpc.jfmpc_620_23 [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Boulton K. H., Dettmar P. W. 2022. A narrative review of the prevalence of gastroesophageal reflux disease (GERD). Annals of Esophagus, 5, Article 7. 10.21037/aoe-20-80 [DOI] [Google Scholar]
  7. Buczkowska M., Górski M., Domagalska J., Buczkowski K., Nowak P. 2022. Type D personality and health behaviors in people living with obesity. International Journal of Environmental Research and Public Health, 19(22), Article 14650. 10.3390/ijerph192214650 [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Can I., Tuman T. C. 2020. The effect of Type D personality on quality of life, sleep quality, anxiety and depression in patients with myofascial pain syndrome. Psychiatry and Behavioral Sciences, 10(2), 90–94. 10.5455/PBS.20191106080151 [DOI] [Google Scholar]
  9. Chan Y., Ching J. Y. L., Cheung C. M. Y., Tsoi K. K. F., Polder-Verkiel S., Pang S. H. Y., Quan W. L., Kee K. M., Chan F. K. L., Sung J. J. Y., Wu J. C. Y. 2010. Development and validation of a disease-specific quality of life questionnaire for gastro-esophageal reflux disease: The GERD-QoL questionnaire. Alimentary Pharmacology & Therapeutics, 31(3), 452–460. 10.1111/j.1365-2036.2009.04187.x [DOI] [PubMed] [Google Scholar]
  10. Chandran S., Raman R., Kishor M., Nandeesh H. P. 2023. A randomized control trial of mindfulness-based intervention in relief of symptoms of anxiety and quality of life in gastroesophageal reflux disease. Annals of Indian Psychiatry, 7(2), 107–114. 10.4103/aip.aip_82_22 [DOI] [Google Scholar]
  11. Chen J., Brady P. 2019. Gastroesophageal reflux disease: Pathophysiology, diagnosis, and treatment. Gastroenterology Nursing, 42(1), 20–28. 10.1097/SGA.0000000000000359 [DOI] [PubMed] [Google Scholar]
  12. Chhabra P., Ingole N. 2022. Gastroesophageal reflux disease (GERD): Highlighting diagnosis, treatment, and lifestyle changes. Cureus, 14(8), Article e28563. 10.7759/cureus.28563 [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Delshad S. D., Almario C. V., Chey W. D., Spiegel B. M. R. 2020. Prevalence of gastroesophageal reflux disease and proton pump inhibitor-refractory symptoms. Gastroenterology, 158(5), 1250–1261. 10.1053/j.gastro.2019.12.014 [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Denollet J. 2005. DS14: Standard assessment of negative affectivity, social inhibition, and Type D personality. Psychosomatic Medicine, 67(1), 89–97. 10.1097/01.psy.0000149256.81953.49 [DOI] [PubMed] [Google Scholar]
  15. Fattouh N., Hallit S., Salameh P., Choueiry G., Kazour F., Hallit R. 2019. Prevalence and factors affecting the level of depression, anxiety, and stress in hospitalized patients with a chronic disease. Perspectives in Psychiatric Care, 55(4), 592–599. 10.1111/ppc.12369 [DOI] [PubMed] [Google Scholar]
  16. Faul F., Erdfelder E., Buchner A., Lang A. G. 2009. Statistical power analyses using G* Power 3.1: Tests for correlation and regression analyses. Behavior Research Methods, 41(4), 1149–1160. 10.3758/BRM.41.4.1149 [DOI] [PubMed] [Google Scholar]
  17. Fuchs K. H., Musial F., Eypasch E., Meining A. 2022. Gastrointestinal quality of life in gastroesophageal reflux disease: A systematic review. Digestion, 103(4), 253–260. 10.1159/000524766 [DOI] [PubMed] [Google Scholar]
  18. Gębska M., Dalewski B., Pałka Ł, Kołodziej Ł, Sobolewska E. 2022. Chronotype profile, stress, depression level, and temporomandibular symptoms in students with Type D personality. Journal of Clinical Medicine, 11(7), Article 1886. 10.3390/jcm11071886 [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Han C., Jo S. A., Kwak J. H., Pae C. U., Steffens D., Jo I., Park M. H. 2008. Validation of the Patient Health Questionnaire-9 Korean version in the elderly population: The Ansan geriatric study. Comprehensive Psychiatry, 49(6), 218–223. 10.1016/j.comppsych.2007.08.006 [DOI] [PubMed] [Google Scholar]
  20. Hansel S. L., Umar S. B., Lunsford T. N., Harris L. A., Dibaise J. K., Crowell M. D. 2010. Personality traits and impaired health-related quality of life in patients with functional gastrointestinal disorders. Clinical Gastroenterology and Hepatology, 8(2), 220–222. 10.1016/j.cgh.2009.10.008 [DOI] [PubMed] [Google Scholar]
  21. Iovino P., Vellone E., Cedrone N., Riegel B. 2023. A middle-range theory of social isolation in chronic illness. International Journal of Environmental Research and Public Health, 20(6), Article 4940. 10.3390/ijerph20064940 [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Jung H. K., Choi M. G., Baek M. K., Wu J. C. Y. 2018. Development and psychometric assessment of a self-evaluation questionnaire for gastroesophageal reflux disease. Journal of Neurogastroenterology and Motility, 24(4), 584–592. 10.5056/jnm18085 [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Kim S. R., Kim S., Cho B. H., Yu S., Cho K. H. 2021. Influence of Type D personality on health-promoting behaviors and quality of life in stroke patients: A cross-sectional study in South Korea. Journal of Stroke and Cerebrovascular Diseases, 30(5), Article 105721. 10.1016/j.jstrokecerebrovasdis.2021.105721 [DOI] [PubMed] [Google Scholar]
  24. Kim S. R., Nho J. H., Nam J. H. 2018. Relationships among Type-D personality, symptoms and quality of life in patients with ovarian cancer receiving chemotherapy. Journal of Psychosomatic Obstetrics & Gynecology, 39(4), 289–296. 10.1080/0167482X.2017.1372416 [DOI] [PubMed] [Google Scholar]
  25. Kim S. R., Nho J. H., Kim H. Y., Ko E., Jung S., Kim I. Y., Jang W. Y. 2021. Type-D personality and quality of life in patients with primary brain tumors. European Journal of Cancer Care (Engl), 30(2), Article e13371. 10.1111/ecc.13371 [DOI] [PubMed] [Google Scholar]
  26. Kim S. R., Nho J. H., Kim J. Y., Hur J. 2020. Effects of a lifestyle intervention based on Type D personality in overweight and obese middle-aged women: A feasibility study. Worldviews on Evidence-Based Nursing, 17(5), 393–403. 10.1111/wvn.12457 [DOI] [PubMed] [Google Scholar]
  27. Kline R. B. 2023. Principles and practice of structural equation modeling (4th ed.). Guilford Press. [Google Scholar]
  28. Kroenke K., Spitzer R. L., Williams J. B. 2001. The PHQ-9: Validity of a brief depression severity measure. Journal of General Internal Medicine, 16(9), 606–613. 10.1046/j.1525-1497.2001.016009606.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Lail G., Hanif F. M., Lail A., Haque M. M., Tasneem A. A., Luck N. H. 2019. Factors influencing quality of life in patients with gastroesophageal reflux disease in a tertiary care hospital in Pakistan. Journal of the College of Physicians and Surgeons--Pakistan, 29(9), 882–885. 10.29271/jcpsp.2019.09.882 [DOI] [PubMed] [Google Scholar]
  30. Lee A. S., Lee J. S., He Z., Ryu J. H. 2020. Reflux-aspiration in chronic lung disease. Annals of the American Thoracic Society, 17(2), 155–164. 10.1513/AnnalsATS.201906-427CME [DOI] [PubMed] [Google Scholar]
  31. Lim H. E., Lee M.-S., Ko Y.-H., Park Y.-M., Joe S.-H., Kim Y.-K., Han C., Lee H.-Y., Pedersen S. S., Denollet J. 2011. Assessment of the Type D personality construct in the Korean population: A validation study of the Korean DS14. Journal of Korean Medical Science, 26(1), 116–123. 10.3346/jkms.2011.26.1.116 [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Maret-Ouda J., Markar S. R., Lagergren J. 2020. Gastroesophageal reflux disease: A review. JAMA, 324(24), 2536–2547. 10.1001/jama.2020.21360 [DOI] [PubMed] [Google Scholar]
  33. Mohammad S., Chandio B., Soomro A. A., Lakho S., Ali Z., Ali Soomro Z., Shaukat F. 2019. Depression and anxiety in patients with gastroesophageal reflux disorder with and without chest pain. Cureus, 11(11), Article e6103. 10.7759/cureus.6103 [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Nejati M., Sharifinia A., Maleki M., Bayazi M. H. 2022. Comparison of the effectiveness of cognitive-behavioral group intervention for coronary heart disease and cognitive therapy in groups on Type D personality and psychological distress on coronary heart patients- a randomized clinical trial. Current Psychology: A Journal for Diverse Perspectives on Diverse Psychological Issues, 41(6), 4001–4011. 10.1007/s12144-020-00917-8 [DOI] [Google Scholar]
  35. Nirwan J. S., Hasan S. S., Babar Z. U. D., Conway B. R., Ghori M. U. 2020. Global prevalence and risk factors of gastro-esophageal reflux disease (GORD): Systematic review with meta-analysis. Scientific Reports, 10(1), Article 5814. 10.1038/s41598-020-62795-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Park Y. M., Kim H. Y., Kim J. Y., Kim S. R., Choe Y. H. 2022. Relationship between Type D personality, symptoms, cancer stigma, and quality of life among patients with lung cancer. European Journal of Oncology Nursing, 57, Article 102098. 10.1016/j.ejon.2022.102098 [DOI] [PubMed] [Google Scholar]
  37. Radovanovic D., Pini S., Rizzi M., Franceschi E., Santus P. 2021. Prevalence and influence of gastroesophageal reflux symptoms on sleep apnea and sleepiness. European Journal of Internal Medicine, 84, 115–117. 10.1053/j.gastro.2019.12.014 [DOI] [PubMed] [Google Scholar]
  38. Raykh O. I., Sumin A. N., Korok E. V. 2022. The influence of personality Type D on cardiovascular prognosis in patients after coronary artery bypass grafting: Data from a 5-year follow-up study. International Journal of Behavioral Medicine, 29, 46–56. 10.1007/s12529-021-09992-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Sandhu D. S., Fass R. 2018. Stress and gastroesophageal reflux disease. Proceeding of the Shevchenko Scientific Society. Medical Sciences, 54(2), 10–15. 10.25040/ntsh2018.02.010 [DOI] [Google Scholar]
  40. Seo J. G., Park S. P. 2015. Validation of the Generalized Anxiety Disorder-7 (GAD-7) and GAD-2 in patients with migraine. Journal of Headache and Pain, 16, Article 97. 10.1186/s10194-015-0583-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Spitzer R. L., Kroenke K., Williams J. B., Löwe B. 2006. A brief measure for assessing generalized anxiety disorder: The GAD-7. Archives of Internal Medicine, 166(10), 1092–1097. 10.1001/archinte.166.10.1092 [DOI] [PubMed] [Google Scholar]
  42. Wang R., Wang J., Hu S. 2021. Study on the relationship of depression, anxiety, lifestyle and eating habits with the severity of reflux esophagitis. BMC Gastroenterology, 21, Article 127. 10.1186/s12876-021-01717-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Wickramasinghe N., Thuraisingham A., Jayalath A., Wickramasinghe D., Samarasekara N., Yazaki E., Devanarayana N. M. 2023. The association between symptoms of gastroesophageal reflux disease and perceived stress: A countrywide study of Sri Lanka. PLOS ONE, 18(11), Article e0294135. 10.1371/journal.pone.0294135 [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Zamani M., Alizadeh-Tabari S., Chan W. W., Talley N. J. 2023. Association between anxiety/depression and gastro-esophageal reflux: A systematic review and meta-analysis. The American Journal of Gastroenterology, 118(12), 2133–2143. 10.14309/ajg.00000000000024111 [DOI] [PubMed] [Google Scholar]
  45. Zhang M., Hou Z. K., Huang Z. B., Liu F. B. 2021. Dietary and lifestyle factors related to gastroesophageal reflux disease: A systematic review. Therapeutics and Clinical Risk Management, 17, 305–323. 10.2147/TCRM.S296680 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Nursing Research are provided here courtesy of Wolters Kluwer Health

RESOURCES